Eckert & Ziegler BEBIG Wins Major Tender in Bangladesh
(Thomson Reuters ONE) -
Seneffe, Belgium, November 4, 2013, Eckert & Ziegler BEBIG announces to have
received an order for the delivery of their state-of-the art MultiSource®
afterloaders for HDR brachytherapy representing one of the largest single orders
ever received by the company.
The decision in favour of MultiSource® was driven by the systems unique
miniaturized cobalt-60 source as well as exclusive safety features enabling for
a high level of accuracy. "Due to its technical characteristics and the long
half-life of the isotope used, our afterloader is ideal for the region. The
radiation source only needs to be replaced every five years," said Abel
Luzuriaga, Managing Director of Eckert & Ziegler BEBIG.
A part of the ordered devices will already be delivered within the next month
while the remaining afterloaders are expected in Bangladesh in the first quarter
of 2014. The deal has a total value of around 3.1 million ? and was initiated by
Eckert & Ziegler BEBIG India.
"We are pleased to see that emerging countries in Asia, Africa and South America
are increasingly gaining access to the latest medical infrastructure that has
long been available in other parts of the world. Our range of MultiSource®
devices with their distinguished characteristics is exactly what decision-makers
are looking for," Abel Luzuriaga added.
The tender was advertised in the context of the "Health, Population & Nutrition
Sector Development Program (HPNSDP)". Amongst others, the five year program aims
to enhance the cancer treatment in The People's Republic of Bangladesh that is
facing rising incidences of the disease. It is the third sector-wide program of
its kind in the country. Supported by the European Union, the World Bank,
UNICEF, the World Health Organization (WHO) and 17 more development partners,
the program will end in June 2016.
For more information regarding the MultiSource® system, please see
http://www.bebig.eu/home/products/hdr-brachytherapy.html
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device
segment of the health care industry.
Its core business is the treatment of cancer using brachytherapy, a special form
of radiation therapy. Eckert & Ziegler BEBIG is a leader in brachytherapy in
Europe. The company headquarters are in Belgium, with a production facility in
Germany and subsidiaries throughout Europe, in India and Brazil. In addition,
Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to
support the international marketing of its product line.
The company's products and equipment are intended for use by oncologists,
radiologists, urologists, and medical physicists. Eckert & Ziegler BEBIG employs
190 people.
The company has been listed on the Euronext stock exchange since April 1997.
Contact:
Claudia Wolf, Head of Marketing, Tel: +49 30 94 10 84 272, marketing(at)bebig.eu
Karolin Riehle, Investor Relations, Tel. + Tel.: +32 (0) 64 520 808, ir(at)bebig.eu
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE
[HUG#1740124]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Pasinex Resources Limited Commences U/G Drilling Operations at Pinargozu Zinc Project in TurkeyDatum: 04.11.2013 - 07:45 Uhr
Sprache: Deutsch
News-ID 312036
Anzahl Zeichen: 3904
contact information:
Town:
Seneffe
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 269 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Eckert & Ziegler BEBIG Wins Major Tender in Bangladesh"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert & Ziegler BEBIG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
